COR
Cencora, Inc.
NYSE · Healthcare · Medical - Distribution · US
$330.95
−1.86%Year over year
Reported trailing growth
- Revenue
- +5.1%
- EBITDA
- +28.0%
- EBIT
- +25.1%
- EPS
- +38.1%
- Free cash flow
- +255.7%
- Operating cash flow
- +176.7%
Forward estimates
Based on analyst estimates
- Revenue
- +4.7%
- EBITDA
- +28.8%
- EPS
- +43.8%
Three-year CAGR
- Revenue
- +10.4%
- EBITDA
- +6.3%
- EBIT
- +9.9%
- Net income
- -2.9%
- EPS
- -0.5%
- Free cash flow
- +13.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026